Johnson & Johnson's Covid-19 vaccine related to autoimmune disorder, the Washington Post reported on Monday, citing four people familiar with the matter.
Recently, NITI Aayog member (Health) Dr VK Paul has confirmed that India is in talks with US pharma giant J&J for their single-dose Covid-19 vaccine named Janssen.
Dr Paul said, "We are in talks with Johnson & Johnson regarding their single-dose vaccine." He said that "as per the plan, this vaccine will also be produced in Hyderabad's Bio E." Johnson & Johnson had earlier said that its Covid-19 vaccine showed strong promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly.